Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06711965 · ClinicalTrials.gov registry record · NA

Interactive Design of Patient-Specific Molds for Tissue Shaping

A NA study of Mastectomy, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT06711965 is a NA study of Mastectomy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 160 participants, above the 113-participant average among 8 other Mastectomy trials with a reported enrollment target (42% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06711965, a NA study of Mastectomy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to develop clinical decision-support algorithms for designing participants-specific breast molds for tissue shaping. Autologous breast reconstruction is an important part of breast cancer rehabilitation for many participants. Our goal is to increase the efficiency of autologous breast reconstruction by helping the surgeon design participants-specific molds for shaping tissue into an acceptable breast form.

Conditions Studied

Interventions

  • PROCEDURE Standard of care reconstruction
  • PROCEDURE Surgery, Breast Mold

Study Locations (1)

Texas

  • The University of Texas M. D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-07-17
Est. Completion 2030-08-01
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT06711965

The ClinicalTrials.gov registry entry for NCT06711965 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 113-participant average among 8 other Mastectomy trials with a reported enrollment target (42% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mastectomy appearing as the primary indexed condition, and to 2 interventions - of which Standard of care reconstruction is the first listed.

NCT06711965 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06711965 about?

NCT06711965 is a clinical study titled "Interactive Design of Patient-Specific Molds for Tissue Shaping". The goal of this study is to develop clinical decision-support algorithms for designing participants-specific breast molds for tissue shaping. Autologous breast reconstruction is an important part of breast cancer rehabilitation for many participants. Our goal is to increase the efficiency of autolo...

What is the current status of trial NCT06711965?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-07-17. Estimated completion is 2030-08-01.

What conditions does trial NCT06711965 study?

This clinical trial studies the following conditions: Mastectomy.

What interventions are being tested in trial NCT06711965?

The interventions under investigation include: Standard of care reconstruction (PROCEDURE), Surgery, Breast Mold (PROCEDURE).

Who is sponsoring clinical trial NCT06711965?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06711965 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mastectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.